SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-004197
Filing Date
2021-01-07
Accepted
2021-01-07 16:20:52
Documents
6
Period of Report
2021-01-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d82298d8k.htm 8-K 23736
2 EX-1.1 d82298dex11.htm EX-1.1 173925
3 EX-5.1 d82298dex51.htm EX-5.1 6468
4 EX-99.1 d82298dex991.htm EX-99.1 8065
5 EX-99.2 d82298dex992.htm EX-99.2 444850
6 GRAPHIC g82298dsp045.jpg GRAPHIC 3432
  Complete submission text file 0001193125-21-004197.txt   663137
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 21514431
SIC: 2836 Biological Products, (No Diagnostic Substances)